SE448094B - Beta-laktonderivat av 2-hydroxi-cyklopentan-karboxylsyra, sett for framstellning derav samt farmaceutiska kompositioner, vilka som aktiv komponent innehaller dessa foreningar - Google Patents
Beta-laktonderivat av 2-hydroxi-cyklopentan-karboxylsyra, sett for framstellning derav samt farmaceutiska kompositioner, vilka som aktiv komponent innehaller dessa foreningarInfo
- Publication number
- SE448094B SE448094B SE7908439A SE7908439A SE448094B SE 448094 B SE448094 B SE 448094B SE 7908439 A SE7908439 A SE 7908439A SE 7908439 A SE7908439 A SE 7908439A SE 448094 B SE448094 B SE 448094B
- Authority
- SE
- Sweden
- Prior art keywords
- formula
- compound
- hydroxy
- group
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7834183A FR2443466A1 (fr) | 1978-12-05 | 1978-12-05 | Nouvelles b-lactones derivees de l'acide 2-hydroxy cyclopentane carboxylique, leur procede de preparation et leur application comme medicaments |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7908439L SE7908439L (sv) | 1980-06-06 |
| SE448094B true SE448094B (sv) | 1987-01-19 |
Family
ID=9215690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7908439A SE448094B (sv) | 1978-12-05 | 1979-10-11 | Beta-laktonderivat av 2-hydroxi-cyklopentan-karboxylsyra, sett for framstellning derav samt farmaceutiska kompositioner, vilka som aktiv komponent innehaller dessa foreningar |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US4264623A (de) |
| EP (1) | EP0012072B1 (de) |
| JP (1) | JPS5585579A (de) |
| AT (1) | AT376216B (de) |
| BE (1) | BE880420A (de) |
| CA (1) | CA1143740A (de) |
| CH (1) | CH642961A5 (de) |
| DE (1) | DE2949003A1 (de) |
| FR (1) | FR2443466A1 (de) |
| GB (1) | GB2042511B (de) |
| IT (1) | IT1164769B (de) |
| NL (1) | NL7908796A (de) |
| SE (1) | SE448094B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5447717A (en) * | 1993-02-25 | 1995-09-05 | Merck & Co., Inc. | Cholesterol-lowering agents |
| CN100537566C (zh) * | 2006-03-02 | 2009-09-09 | 中国科学院化学研究所 | 一种有机染料及其制备方法与应用 |
| KR102573427B1 (ko) * | 2020-10-30 | 2023-09-01 | 단국대학교 천안캠퍼스 산학협력단 | 옥상 녹화 습지 서식처 조성 방법 |
| KR102615814B1 (ko) * | 2020-10-30 | 2023-12-21 | 단국대학교 천안캠퍼스 산학협력단 | 옥상 녹화 습지 서식처 자동 관리 시스템 |
| KR102583298B1 (ko) * | 2022-10-19 | 2023-09-26 | 주식회사 비아 | 자율주행 시설로봇 및 이를 이용한 시설관리 자동화 시스템 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4024179A (en) * | 1972-11-08 | 1977-05-17 | Pfizer Inc. | Substituted ω-pentanorprostaglandins |
| HU171155B (hu) * | 1973-04-30 | 1977-11-28 | Pfizer | Sposob poluchenija oksa-prostaglandinov |
| FR2344285A1 (fr) * | 1976-03-19 | 1977-10-14 | Roussel Uclaf | Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments |
| US4221809A (en) * | 1978-10-23 | 1980-09-09 | Roussel Uclaf | β-Lactones of 2-hydroxy-cyclopentanecarboxylic acid |
| FR2383936A2 (fr) * | 1977-03-18 | 1978-10-13 | Roussel Uclaf | Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments |
-
1978
- 1978-12-05 FR FR7834183A patent/FR2443466A1/fr active Granted
-
1979
- 1979-10-11 SE SE7908439A patent/SE448094B/sv not_active IP Right Cessation
- 1979-11-16 US US06/094,771 patent/US4264623A/en not_active Expired - Lifetime
- 1979-11-20 AT AT0739479A patent/AT376216B/de not_active IP Right Cessation
- 1979-11-23 EP EP79400905A patent/EP0012072B1/de not_active Expired
- 1979-12-03 JP JP15570579A patent/JPS5585579A/ja active Granted
- 1979-12-04 IT IT50981/79A patent/IT1164769B/it active
- 1979-12-04 GB GB7941741A patent/GB2042511B/en not_active Expired
- 1979-12-04 CH CH1074679A patent/CH642961A5/fr not_active IP Right Cessation
- 1979-12-04 CA CA000341162A patent/CA1143740A/fr not_active Expired
- 1979-12-04 BE BE0/198412A patent/BE880420A/fr not_active IP Right Cessation
- 1979-12-05 DE DE19792949003 patent/DE2949003A1/de active Granted
- 1979-12-05 NL NL7908796A patent/NL7908796A/nl not_active Application Discontinuation
-
1980
- 1980-12-15 US US06/216,124 patent/US4308209A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR2443466B1 (de) | 1982-03-19 |
| US4264623A (en) | 1981-04-28 |
| BE880420A (fr) | 1980-06-04 |
| AT376216B (de) | 1984-10-25 |
| DE2949003A1 (de) | 1980-06-19 |
| NL7908796A (nl) | 1980-06-09 |
| CA1143740A (fr) | 1983-03-29 |
| CH642961A5 (fr) | 1984-05-15 |
| IT7950981A0 (it) | 1979-12-04 |
| EP0012072A2 (de) | 1980-06-11 |
| DE2949003C2 (de) | 1990-12-06 |
| ATA739479A (de) | 1984-03-15 |
| JPS6365668B2 (de) | 1988-12-16 |
| SE7908439L (sv) | 1980-06-06 |
| GB2042511A (en) | 1980-09-24 |
| EP0012072A3 (en) | 1980-08-06 |
| JPS5585579A (en) | 1980-06-27 |
| IT1164769B (it) | 1987-04-15 |
| FR2443466A1 (fr) | 1980-07-04 |
| US4308209A (en) | 1981-12-29 |
| GB2042511B (en) | 1983-05-18 |
| EP0012072B1 (de) | 1984-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU624663B2 (en) | Diaryl ether derivatives | |
| US4545938A (en) | Chemical synthesis | |
| SE448094B (sv) | Beta-laktonderivat av 2-hydroxi-cyklopentan-karboxylsyra, sett for framstellning derav samt farmaceutiska kompositioner, vilka som aktiv komponent innehaller dessa foreningar | |
| DE68916174T2 (de) | Mevalonolactone vom Thienopyridin-Typ. | |
| US3980700A (en) | Prostaglandin intermediates and optically active isomers thereof | |
| DE4038128A1 (de) | 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate | |
| JPH06502390A (ja) | シクロペンタン誘導体、その製法及びその薬剤学的使用 | |
| HU203722B (en) | Process for producing substituted hydroxyamines and pharmaceutical compositions containing them | |
| HU199411B (en) | Process for producing cyclopentyl ether derivatives and pharmaceutical compositions containing them as active components | |
| CH620675A5 (de) | ||
| US4535084A (en) | Certain 4-(2-hydroxyethylthiomethyl)pyridines and derivatives thereof having immunoregulatory activity | |
| US3984455A (en) | Prostaglandin E1 analogs | |
| JPH044312B2 (de) | ||
| JP2005536463A (ja) | １７α−フルオロアルキル−１１β−ベンズアルドキシムステロイド、それらの製造方法、これらのステロイド類を含有する製剤及び医薬品製造のためのそれらの使用 | |
| US5389671A (en) | 4- or 5-(substituted sulfonyl)methyl-3(2H)-furanones | |
| DE68905219T2 (de) | 2-substituierte 2-cyclopentenone. | |
| GB2169803A (en) | Compositions for treating hormone dependent neoplasias | |
| FR2533928A1 (fr) | Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments | |
| DE3688161T2 (de) | Gegebenenfalls etherifizierte oder esterifizierte in Stellung 2 substituierte 4-OH-Chinolincarbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Anwendung als Arzneimittel und diese enthaltende Zubereitungen. | |
| JPS6345295A (ja) | アンドロスタンの新誘導体 | |
| US4404372A (en) | 15-Substituted-ω-pentanorprostaglandin derivatives | |
| EP0000073A1 (de) | 24-Dehydrovitamin D3 Derivate und Verfahren zu ihrer Herstellung und diese enthaltende Präparate | |
| EP0344096B1 (de) | Neue Leukotrien-B4-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| US4035360A (en) | Magnesium salts of 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanoprostaglandins | |
| US4282245A (en) | Dibenzothiepin derivatives and a process for producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7908439-8 Effective date: 19920510 Format of ref document f/p: F |